[Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection]

Rev Chilena Infectol. 2018;35(1):29-35. doi: 10.4067/s0716-10182018000100029.
[Article in Spanish]

Abstract

Background Community acquired urinary tract infections (CaUTI) caused by strains of extended-spectrum β-lactamases (ESBL) - producing Escherichia coli, mainly by strains carrying the blaCTX-M-15 gene, is a growing phenomenon worldwide. Aim To determine the antibiotic susceptibility pattern of ESBL-producing E. coli as cause of CaUTI and to identify their molecular pattern. Methods A descriptive study was performed in the city of Oaxaca, Mexico, from where 288 strains of CaUTI-producing strains of E. coli in adults with possible UTI were isolated. The CLSI criteria was followed to determine the antimicrobial susceptibility patterns, and their molecular characterization was performed by using PCR. Results 31.3% of E. coli strains isolated in our population were ESBL producers, which presented higher levels of antibiotic resistance than those of non-producers of these enzymes. 95.6% of the studied strains were carriers of the blaCTX-M gene. Conclusions One-third of the Ca-UTI caused by E. coli in our population are caused by ESBL-producing strains, which present high levels of resistance to the antibiotics widely used in our community. This situation considerably decreases the number of antibiotics available for an empiric treatment against these infections.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Community-Acquired Infections / microbiology
  • Electrophoresis
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / genetics*
  • Escherichia coli / isolation & purification
  • Escherichia coli Infections / microbiology
  • Female
  • Genotype
  • Humans
  • Male
  • Mexico
  • Microbial Sensitivity Tests
  • Middle Aged
  • Urinary Tract Infections / microbiology*
  • beta-Lactam Resistance
  • beta-Lactamases / drug effects*
  • beta-Lactamases / genetics*
  • beta-Lactamases / isolation & purification

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases